Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients with Calr-Mutated Myelofibrosis

被引：0

作者：

Boluda, Juan Carlos Hernandez ^{[1
]}

Eikema, Dirk-Jan ^{[2
]}

Erazo, Nadia ^{[3
]}

Kroeger, Nicolaus ^{[4
]}

Robin, Marie ^{[5
]}

de Witte, Moniek ^{[6
]}

Finke, Juergen ^{[7
]}

Rambaldi, Alessandro ^{[8
]}

Broers, Annoek E. C. ^{[9
]}

Raida, Ludek ^{[10
,11
]}

Schaap, Nicolaas ^{[12
]}

Chiusolo, Patrizia ^{[13
]}

Verbeek, Mareike ^{[14
]}

Choi, Goda ^{[15
]}

Halaburda, Kazimierz ^{[16
]}

Kulagin, Alexander D. ^{[17
]}

Labussiere-Wallet, Helene ^{[18
]}

Gedde-Dahl, Tobias ^{[19
]}

Rabitsch, Werner ^{[20
]}

Raj, Kavita ^{[21
]}

Drozd-Sokolowska, Joanna ^{[22
]}

Polverelli, Nicola ^{[23
]}

Czerw, Tomasz ^{[24
,25
]}

Yakoub-Agha, Ibrahim ^{[26
]}

McLornan, Donal P. ^{[27
]}

机构：

[1] Hosp Clin Univ, Hematol Dept, Valencia, Spain

[2] EBMT Stat Unit, Leiden, Netherlands

[3] EBMT Leiden Study Unit, Leiden, Netherlands

[4] Univ Med Ctr Hamburg Eppendorf, Dept Stem Cell Transplantat, Hamburg, Germany

[5] Univ Paris Cite, Hop St Louis, AP HP, Paris, France

[6] UMC Utrecht, Utrecht, Netherlands

[7] Univ Freiburg, Fac Med, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany

[8] Azienda Socio Sanit Terr Papa Giovanni XXIII, Dept Oncol Hematol, Bergamo, Italy

[9] Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands

[10] Palacky Univ Olomouc, Fac Med & Dent, Dept Hematooncol, Olomouc, Czech Republic

[11] Univ Hosp Olomouc, Olomouc, Czech Republic

[12] Radboud Univ Nijmegen, Dept Hematol, Med Ctr, Nijmegen, Netherlands

[13] Fdn Policlin Univ A Gemelli IRCCS, Dept Diagnost Immagini Radioterapia Oncol & Emato, Rome, Italy

[14] TUM, Klinikum Rechts Isar, Munich, Germany

[15] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands

[16] Inst Hematol & Transfus Med, Warsaw, Poland

[17] Pavlov Univ, RM Gorbacheva Res Inst, St Petersburg, Russia

[18] Ctr Hosp Lyon Sud, Hematol Dept 1 G, Pierre Benite, France

[19] Oslo Univ Hosp, Rikshosp, Hematol Dept, Clin Canc Med,Sect Stem Cell Transplantat, Oslo, Norway

[20] Med Univ Vienna, BMT Unit, Vienna Gen Hosp, Internal Med 1, Vienna, Austria

[21] Univ Coll London Hosp NHS Trust, London, England

[22] Med Univ Warsaw, Cent Clin Hosp, Warsaw, Poland

[23] Univ Brescia, Dept Clin & Expt Sci, Unit Blood Dis & Stem Cell Transplantat, ASST Spedali Civili Brescia, Brescia, Italy

[24] Maria Sklodowska Curie Mem Canc Ctr, Gliwice, Poland

[25] Inst Oncol, Gliwice Branch, Gliwice, Poland

[26] Univ Lille, INSERM, U1286, Ctr Hosp Univ Lille LIRIC, Lille, France

[27] Univ Coll London Hosp, Dept Haematol & Stem Cell Transplantat, London, England

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-163048

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：10608 / 10610

页数：3

共 50 条

[41] Assessment of CALR mutations in myelofibrosis patients, post-allogeneic stem cell transplantation
Haslam, Karl
Langabeer, Stephen E.
Molloy, Karen
McMullin, Mary F.
Conneally, Eibhlin
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (05) : 800 - 802
[42] Allogeneic hematopoietic stem cell transplantation for myelofibrosis
Deeg, HJ
Gooley, TA
Flowers, MED
Sale, GE
Slattery, JT
Anasetti, C
Chauncey, TR
Doney, K
Georges, GE
Kiem, HP
Martin, PJ
Petersdorf, EW
Radich, J
Sanders, JE
Sandmaier, BM
Warren, EH
Witherspoon, RP
Storb, R
Appelbaum, FR
BLOOD, 2003, 102 (12) : 3912 - 3918
[43] Allogeneic hematopoietic stem cell transplantation for myelofibrosis
Barosi, Giovanni
Bacigalupo, Andrea
CURRENT OPINION IN HEMATOLOGY, 2006, 13 (02) : 74 - 78
[44] Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis
Popat, Uday
Rondon, Gabriela
Alousi, Amin
Anderlini, Paolo
Andersson, Borje
Hosing, Chitra
de Lima, Marcos
Ciurea, Stefan
Giralt, Sergio
Kebriaei, Partow
Nieto, Yago
Khouri, Issa
Qazilbash, Muzaffar H.
Jones, Roy
Champlin, Richard
BLOOD, 2009, 114 (22) : 900 - 900
[45] Treatment with Foscarnet after Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Is Associated with Long-Term Loss of Renal Function
Foster, Gena G.
Grant, Michael J.
Thomas, Samantha M.
Cameron, Blake
Raiff, Doug
Corbet, Kelly
Loitsch, Gavin
Ferreri, Christopher
Horwitz, Mitchell
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (09) : 1597 - 1606
[46] Biomarkers in a phase 1b study of investigational microbiome therapeutic SER-155 in adults undergoing allogeneic hematopoietic cell transplantation (allo-HCT).
Ponce, Doris M.
Pandian, Swarna
Van den Brink, Marcel R. M.
Kosuri, Satyajit
Khera, Nandita
DeFilipp, Zachariah Michael
Tejura, Bindu
Lichter, David I.
Chafee, Meghan
Bardhan, Kankana
Hicks, Nathan D.
Walsh, Emily
Lombardo, Mary-Jane
Ford, Christopher B.
Von Moltke, Lisa
Henn, Matthew R.
Peled, Jonathan U.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[47] The impact of disparity in short tandem repeats (STRS) analysis on the outcome of allogeneic hematopoietic cell transplantation (allo-HCT) from HLA-identical sibling donors
Serbest, E.
Topcuoglu, P. T.
Dalva, K. D.
Soydan, E. S.
Arslan, O. A.
Ozcan, M. O.
Demirer, T. D.
Akan, H. A.
Konuk, Nx
Uysal, A. U.
Ilhan, O. I.
Gutman, G. G.
Beksac, M. B.
Arat, M. A.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 517 - 517
[48] OUTCOMES OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) IN PATIENTS WITH MYELOFIBROSIS (MF) EXPOSED TO JAK1/2 INHIBITORS
Shanavas, M.
Popat, U.
Michaelis, L. C.
Fauble, V.
Mclornan, D.
Klisovic, R.
Mascarenhas, J.
Tamari, R.
Arcasoy, M.
Davies, J.
Gergis, U.
Ukaegbu, O.
Kamble, R.
Storring, J.
Majhail, N. S.
Romee, R.
Lew, J.
Pagliuca, A.
Vasu, S.
Ernst, B.
Atenafu, E.
Hanif, A.
Champlin, R.
Hari, P.
Gupta, V.
HAEMATOLOGICA, 2015, 100 : 162 - 163
[49] Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC)
Carlos Jiménez-Vicente
Jordi Esteve
Mónica Baile-González
Estefanía Pérez-López
Carmen Martin Calvo
Clara Aparicio
Itziar Oiartzabal Ormategi
Albert Esquirol
Felipe Peña-Muñoz
Sara Fernández-Luis
Inmaculada Heras Fernando
Ana Pilar González-Rodríguez
Alberto López-García
Jose Luis López-Lorenzo
Tamara Torrado
Adolfo Jesús Sáez Marín
Cynthia Acosta Fleytas
Lucía García
Sara Villar
Silvia Filaferro
Pascual Balsalobre
María Jesús Pascual Cascón
María Queralt Salas
Blood Cancer Journal, 15 (1)
[50] Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy: a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT)
Meral Beksac
Nicolaus Kröger
Jennifer L. Byrne
Arnold Ganser
Zeynep Arzu Yeğin
Stefan Schönland
Bone Marrow Transplantation, 2021, 56 : 529 - 531

← 1 2 3 4 5 →